Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Herpes Labialis (Oral Herpes) - Overview
Herpes Labialis (Oral Herpes) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Herpes Labialis (Oral Herpes) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Herpes Labialis (Oral Herpes) - Companies Involved in Therapeutics Development
AiCuris AG
Astellas Pharma Inc
Brandenburg Antiinfektiva GmbH
Dobecure SL
Heidelberg Immunotherapeutics Gmbh
Jupiter Wellness Inc
noViricides Inc
Provention Bio Inc
Ratiol Vaccines Inc
Shulov Innovative Science Ltd
Vironova Medical AB
Herpes Labialis (Oral Herpes) - Drug Profiles
amemevir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Aspidasept - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
B-220 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ethamsylate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
HDIT-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
JW-400 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NVHHV-101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
pritelivir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PRV-300 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RVX-101HSV1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule for Herpes Labialis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZEP-3 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ZEP-4 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Herpes Labialis (Oral Herpes) - Dormant Projects
Herpes Labialis (Oral Herpes) - Discontinued Products
Herpes Labialis (Oral Herpes) - Product Development Milestones
Featured News & Press Releases
Aug 23, 2017: AiCuris Announces Fil Patient Treated in Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Dec 01, 2016: AiCuris Announces Start of LipP 1: First Subject Enrolled in the Clinical Phase 2 Trial with Topical Pritelivir for the Treatment of recurrent Labial Herpes
Nov 05, 2010: AiCuris To Present Preclinical And Phase I Data Of Anti-HSV Drug AIC316 At Antivirals Congress
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Herpes Labialis (Oral Herpes), 2021
Number of Products under Development by Companies, 2021
Number of Products by Targets, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Herpes Labialis (Oral Herpes), 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Herpes Labialis (Oral Herpes) - Pipeline by AiCuris AG, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Astellas Pharma Inc, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Brandenburg Antiinfektiva GmbH, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Dobecure SL, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Heidelberg Immunotherapeutics Gmbh, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Jupiter Wellness Inc, 2021
Herpes Labialis (Oral Herpes) - Pipeline by NanoViricides Inc, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Provention Bio Inc, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Rational Vaccines Inc, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Shulov Innovative Science Ltd, 2021
Herpes Labialis (Oral Herpes) - Pipeline by Vironova Medical AB, 2021
Herpes Labialis (Oral Herpes) - Dormant Projects, 2021
Herpes Labialis (Oral Herpes) - Discontinued Products, 2021